Research and innovation in Texas A&M University's biomedical engineering department often centers around clinical impact on ...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July ...

A federal judge ordered on Tuesday that construction be halted on President Trump’s proposed White House ballroom, to be ...

Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA ...

New Democrats have chosen Avi Lewis to lead their party, tasking him with rebuilding a caucus that has fallen out of official status in the House of Commons, and charting a path back to federal ...

Larry David is the indisputable king of brutal honesty. But if anyone comes close, it’s Robby Hoffman, the suddenly ...

Peter Richardson has written books about the Grateful Dead, gonzo journalist Hunter S. Thompson and the muckraking leftist magazine Ramparts. So it seemed like a natural progression for him to write ...

Miners, loggers and dam builders all flocked to this Clearwater River town at one time or another, helping to give the community its rugged charm ...

The Wild Rise of Rolling Stone Magazine,” Peter Richardson chronicles the upstart periodical’s rocky heyday, from its Summer of Love launch in 1967 to its controversial move to New York City a decade ...

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit ...